Endogenous cholesterol synthesis is associated with VLDL-2 apoB-100 production in healthy humans

被引:24
作者
Prinsen, BHCMT
Romijn, JA
Bisschop, PH
de Barse, MMJ
Barrett, PHR
Ackermans, M
Berger, R
Rabelink, TJ
de Sain-van der Velden, MGM [1 ]
机构
[1] Univ Utrecht, Ctr Med, Dept Metab Dis, Utrecht, Netherlands
[2] Univ Utrecht, Ctr Med, Dept Vasc Med & Metab, Utrecht, Netherlands
[3] Leiden Univ, Med Ctr, Dept Endocrinol, Leiden, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, Amsterdam, Netherlands
[5] Univ Western Australia, Dept Med, Perth, WA, Australia
[6] Western Australia Inst Med Res, Perth, WA, Australia
关键词
apolipoprotein B-100; lathosterol; very low density lipoprotein;
D O I
10.1194/jlr.M300023-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Subjects with high plasma cholesterol levels exhibit a high production of VLDL apolipoprotein B-100 (apoB-100), suggesting that cholesterol is a mediator for VLDL production. The objective of the study was to examine whether endogenous cholesterol synthesis, reflected by the lathosterol-cholesterol ratio (I-C ratio), affects the secretory rates of different VLDL subfractions. Ten healthy subjects were studied after overnight fasting. During a 10 h primed, constant infusion of C-13-valine (15 mumol/kg/h), enrichment was determined in apoB-100 from ultracentrifugally isolated VLDL-1 and VLDL-2 by gas chromatography mass spectrometry. The synthesis rates of VLDL-1 apoB-100 and VLDL-2 apoB-100, catabolism, and transfer were estimated by compartmental analysis. Mean VLDL-1 apoB-100 pool size was 90 +/- 15 mg, and mean VLDL-2 apoB-100 pool size was 111 14 mg. Absolute synthesis rate of VLDL-1 apoB-100 was 649 +/- 127 mg/day and 353 +/- 59 mg/day for VLDL-2 apoB-100. There was a strong association between the absolute synthesis rate of VLDL-2 apoB-100 and I,C ratio (r(2) = 0.61, P < 0.01). In contrast, no correlation was observed between L-C ratio and absolute synthesis rate of VLDL-1 apoB-100 (r(2) = 0.302, P = 0.09). In conclusion, these data provide additional support for an independent regulation of VLDL-1 apoB-100 and VLDL-2 apoB-100 production. Endogenous cholesterol synthesis is correlated only with the VLDL-2 apoB-100 production.
引用
收藏
页码:1341 / 1348
页数:8
相关论文
共 46 条
  • [1] A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism - Kinetics of apolipoprotein B during placebo and pravastatin therapy
    AguilarSalinas, CA
    Barrett, PHR
    Pulai, J
    Zhu, XL
    Schonfeld, G
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (01) : 72 - 82
  • [2] AGUILARSALINAS CA, 1995, J LIPID RES, V36, P188
  • [3] EFFECTS OF LOVASTATIN THERAPY ON VERY-LOW-DENSITY LIPOPROTEIN TRIGLYCERIDE-METABOLISM IN SUBJECTS WITH COMBINED HYPERLIPIDEMIA - EVIDENCE FOR REDUCED ASSEMBLY AND SECRETION OF TRIGLYCERIDE-RICH LIPOPROTEINS
    ARAD, Y
    RAMAKRISHNAN, R
    GINSBERG, HN
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (05): : 487 - 493
  • [4] ARAD Y, 1990, J LIPID RES, V31, P567
  • [5] NO EVIDENCE FOR FEEDBACK INHIBITION OF HEPATIC APOLIPOPROTEIN-B (APO-B) PRODUCTION AFTER EXTRACORPOREAL LOW-DENSITY-LIPOPROTEIN PRECIPITATION AS DETERMINED BY [1-C-13]LEUCINE INFUSION IN NORMAL VOLUNTEERS
    ARENDS, J
    BIER, DM
    SCHAFER, G
    ARMSTRONG, VW
    THIERY, J
    SEIDEL, D
    SCHAUDER, P
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1993, 23 (10) : 602 - 614
  • [6] Assmann G, 2001, AM J CARDIOL, V87, p2B, DOI 10.1016/S0002-9149(01)01448-5
  • [7] Hypertriglyceridemia as a cardiovascular risk factor
    Austin, MA
    Hokanson, JE
    Edwards, KL
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A) : 7B - 12B
  • [8] The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs
    Burnett, JR
    Wilcox, LJ
    Telford, DE
    Kleinstiver, SJ
    Barrett, PHR
    Newton, RS
    Huff, MW
    [J]. ENDOCRINOLOGY, 1999, 140 (11) : 5293 - 5302
  • [9] Apolipoprotein B-100 kinetics in visceral obesity: Associations with plasma apolipoprotein C-III concentration
    Chan, DC
    Watts, GF
    Redgrave, TG
    Mori, TA
    Barrett, PHR
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (08): : 1041 - 1046
  • [10] Mechanism of action of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on apolipoprotein B-100 kinetics in visceral obesity
    Chan, DC
    Watts, GF
    Barrett, PHR
    Mori, TA
    Beilin, LJ
    Redgrave, TG
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (05) : 2283 - 2289